Fact Sheets & Analyses

  View more fact sheets and analyses: Expand List

What's New?


Latest news about the TPP

TPP Negotiations Rounds Archive

TPP and Access to Medicines

Canada Chile Peru Vietnam Malaysia Malaysia Malaysia Australia Australia New Zealand New Zealand Japan Japan Japan Brueni Darussalam Singapore Canada

The Trans-Pacific Partnership (TPP) was a proposed free trade agreement between Australia, Brunei Darussalam, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, the United States and Vietnam. Official publication of the text in November 2015 revealed that the U.S. Trade Representative (USTR) was successful in pressuring TPP countries to accept some of its proposed rules that expand pharmaceutical monopoly protections and trade away access to medicines. Resistance to USTR demands prevented some harmful rules from being included in the agreement, but many bad rules remained. By stopping the ratification of the deal in national legislatures like the U.S. Congress, people power prevented the TPP's harmful rules from coming into effect. Continue reading...

Washington Post Editorial Board: "No issue caused more conflict in the latest round of talks — or in the general political debate over the TPP — than the question of intellectual property and other protections for the U.S. pharmaceutical industry." (August 2015)

October 9, 2015 - WikiLeaks releases the TPP intellectual property chapter -- see Public Citizen's analysis here

Trans-Pacific Partnership
Country Resource Page

Leaked Trade Negotiation Texts and Analysis

Find country-specific news, analyses and other resources here. Translations available in Spanish and Vietnamese.

courtesy of mjtmail
The TPP is being negotiated behind closed doors with the negotiation text kept secret from the public. Find leaked texts and analyses here.

Letters and Statements

External Resources

Find letters sent by civil society organizations to their governments and statements on the TPP here.

Explore the websites of partner organizations to find out more about the TPP.

For more info and updates, follow us on Twitter: @PCMedsAccess

Back to Access to Medicines Home Page

Copyright © 2017 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.